文献速递神经肿瘤

WEE1激活介导胶质母细胞瘤对PI3K抑制的耐药

Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.
PubMed 文献 · Neuro Oncol · 2018-01-01

研究在患者来源的胶质瘤起始细胞和已建系GBM细胞中观察到,PI3K抑制后WEE1激酶激活,使Cdc2在Tyr15位点磷酸化并抑制其活性,导致不依赖p53的G2/M期阻滞;抑制WEE1可解除阻滞,联合用药在皮下移植瘤模型中显著抑制肿瘤生长,但因血脑屏障穿透有限,在颅内模型中未显著抑制肿瘤生长。

要点

  • PI3K抑制后WEE1激活,磷酸化Cdc2 Tyr15,导致不依赖p53的G2/M期阻滞。
  • 抑制WEE1可解除G2/M期阻滞,使细胞过早进入有丝分裂并发生有丝分裂灾难和凋亡。
  • WEE1与PI3K联合抑制在皮下移植瘤模型中显著抑制肿瘤生长,但在颅内模型中未显著抑制。

核心结论

  • WEE1是PI3K抑制后激活的适应性耐药基因,抑制WEE1可增强PI3K靶向抑制的效果,作者认为联合抑制WEE1和PI3K可能使GBM的靶向治疗取得成功。

研究设计与样本

  • 研究使用患者来源的胶质瘤起始细胞和已建系GBM细胞,单独或联合给予PI3K抑制剂或WEE1抑制剂,用CellTiter-Blue法评估细胞增殖。
  • 用TUNEL、annexin V染色及cleaved caspase-3和cleaved poly(ADP-ribose) polymerase印迹分析细胞凋亡。
  • 开展皮下移植瘤和原位移植瘤研究评估联合治疗对肿瘤发生的影响,用生物发光成像监测肿瘤生长,并用免疫组化分析肿瘤组织验证信号通路变化。

主要发现

  • PI3K抑制激活WEE1激酶,WEE1使细胞分裂周期蛋白2同源物(Cdc2)在Tyr15位点磷酸化并抑制Cdc2活性,导致不依赖p53的G2/M期阻滞。
  • 抑制WEE1消除G2/M期阻滞,推动细胞过早进入有丝分裂,并通过有丝分裂灾难和凋亡导致细胞死亡。
  • 联合治疗在皮下移植瘤模型中显著抑制肿瘤生长,但在颅内移植瘤模型中未显著抑制肿瘤生长,原因是血脑屏障穿透有限。

局限性

  • 联合治疗在颅内移植瘤模型中未显著抑制肿瘤生长,原因是血脑屏障穿透有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oncogenic activation of phosphatidylinositol-3 kinase (PI3K) signaling plays a pivotal role in the development of glioblastoma (GBM). However, pharmacological inhibition of PI3K has so far not been therapeutically successful due to adaptive resistance through a rapid rewiring of cancer cell signaling. Here we identified that WEE1 is activated after transient exposure to PI3K inhibition and confers resistance to PI3K inhibition in GBM. METHODS: Patient-derived glioma-initiating cells and established GBM cells were treated with PI3K inhibitor or WEE1 inhibitor alone or in combination, and cell proliferation was evaluated by CellTiter-Blue assay. Cell apoptosis was analyzed by TUNEL, annexin V staining, and blotting of cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase. Both subcutaneous xenograft and orthotropic xenograft studies were conducted to evaluate the effects of the combination on tumorigenesis; the tumor growth was monitored by bioluminescence imaging, and tumor tissue was analyzed by immunohistochemistry to validate signaling changes. RESULTS: PI3K inhibition activates WEE1 kinase, which in turn phosphorylates cell division control protein 2 homolog (Cdc2) at Tyr15 and inhibits Cdc2 activity, leading to G2/M arrest in a p53-independent manner. WEE1 inhibition abrogated the G2/M arrest and propelled cells to prematurely enter into mitosis and consequent cell death through mitotic catastrophe and apoptosis. Additionally, combination treatment significantly suppressed tumor growth in a subcutaneous model but not in an intracranial model due to limited blood-brain barrier penetration. CONCLUSIONS: Our findings highlight WEE1 as an adaptive resistant gene activated after PI3K inhibition, and inhibition of WEE1 potentiated the effectiveness of PI3K targeted inhibition, suggesting that a combinational inhibition of WEE1 and PI3K might allow successful targeted therapy in GBM.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Wu S, Wang S, Gao F, et al. Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma. Neuro Oncol. 2018. PMID: 29016926. doi:10.1093/neuonc/nox128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。